| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.05B | 51.12B | 48.22B | 44.69B | 42.15B | 42.15B |
| Gross Profit | 18.35B | 17.66B | 15.88B | 15.44B | 14.64B | 12.80B |
| EBITDA | 5.56B | 5.25B | 4.58B | 3.69B | 3.57B | 2.61B |
| Net Income | 2.21B | 2.20B | 1.93B | 1.61B | 1.47B | 657.27M |
Balance Sheet | ||||||
| Total Assets | 38.65B | 36.68B | 38.09B | 34.11B | 29.42B | 29.47B |
| Cash, Cash Equivalents and Short-Term Investments | 1.55B | 1.52B | 1.33B | 1.69B | 1.07B | 1.10B |
| Total Debt | 6.70B | 1.95B | 4.89B | 3.99B | 2.07B | 3.79B |
| Total Liabilities | 16.73B | 14.55B | 17.08B | 15.42B | 12.03B | 13.22B |
| Stockholders Equity | 21.92B | 22.12B | 20.99B | 18.65B | 17.35B | 16.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.24B | -944.80M | -404.22M | 1.91B | 2.20B |
| Operating Cash Flow | 0.00 | 6.07B | 2.67B | 2.45B | 2.91B | 3.57B |
| Investing Cash Flow | 0.00 | -1.83B | -3.55B | -2.37B | -958.78M | -1.31B |
| Financing Cash Flow | 0.00 | -4.08B | 457.30M | 398.44M | -2.05B | -2.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥230.99B | 12.35 | 13.33% | 3.47% | 4.21% | 23.86% | |
72 Outperform | ¥78.08B | 6.88 | ― | 1.55% | 5.78% | 14.23% | |
72 Outperform | ¥31.57B | 10.02 | ― | 1.23% | 6.74% | 29.20% | |
69 Neutral | ¥55.22B | 20.67 | ― | 4.63% | 7.74% | 0.96% | |
66 Neutral | ¥37.70B | 14.06 | ― | 0.84% | 15.03% | -26.43% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | ¥63.66B | 14.49 | ― | 1.14% | 8.17% | 10.65% |